2025年5月24日 周六
Home > Archive>Volume 26, Issue 4, 2018 >424-428
PDF HTML XML Export Cite reminder
The role of intermedin in diabetes combined with coronary heart disease
Author:
Affiliation:

Department of Cardiology, the Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, China)

Clc Number:

R5

  • Article
    • | |
  • Metrics
    • |
  • Reference
    • |
  • Related
    • |
  • Cited by
    • | |
  • Comments
    Abstract:

    Intermedin (IMD) is a new type of cardiovascular regulatory peptide found in recent years. It is a new member of calciton gene related peptide (CGRP). Previous studies have found that the IMD has important protective effect in ischemia reperfusion. Epidemiological and clinical studies have shown that diabetic population of ischemic heart disease (angina and myocardial infarction), congestive heart failure and the incidence of atherosclerotic lesions caused by disease and its severity is much higher than people without diabetes. Therefore, it remains to be discussed whether the IMD has protective effect in diabetic patients with coronary heart disease. This article reviews the biological characteristics of the IMD and its role in diabetic patients combined with coronary heart disease from basic research to clinical research progress.

    Reference
    Related
    Cited by
Get Citation

ZHANG Qin-Feng, GONG Shu-Wen, LI Hong, DAI Pei, BIAN Yun-Fei, XIAO Chuan-Shi, GAO Fen. The role of intermedin in diabetes combined with coronary heart disease[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2018,26(4):424-428.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:September 01,2017
  • Revised:October 19,2017
  • Online: May 04,2018
Article QR Code

You are the 48614 visitor

Post Code：421001 Fax：0734-8160523

Phone：0734-8160765 E-mail：dmzzbjb@163.net

Editorial Office of Chinese Journal of Arteriosclerosis ® 2025